Faegre Drinker represented Brickell Biotech, Inc., a clinical-stage pharmaceutical company, in a $20 million offering consisting of common stock and warrants.
June 2020
Brickell Biotech Completes $20M Common Stock Offering
United States - Colorado
Lead Contacts
